Biden Administration Buys More Monoclonal Antibody Treatments to Ward Off Shortage
THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading